My friends, there are a few inescapable truths:
- Pharma does not (often) buy "ideas", "frameworks" or "technologies". They buy revenue streams.
- From a Pharma perspective, buying a small Australian biotech costs - the (insignificant) purchase price, covering the risk of the key principles departing, linking into the research management structure, reputational risk, etc.
Phylogica is a discovery focused biotech with a platform technology. Pharma have them exactly where they want them:
Starved for capital (which is cheap for Pharma)
At their beck and call - Pharma has no problems getting the research initiatives they want for chump change.
Why would Pharma change this situation?
From a PYC holder's perspective:
- The current shareprice heavily discounts due to the uncertainties and does not adequately reflect the value of the framework.
- More money will need to be spent to fully develop the framework. We are a long way from significant drug royalties.
However, if they can reasonably achieve cash flow self-sustainability - this will be a fantastic company to hold.
- Forums
- ASX - By Stock
- Ann: Janssen Collaboration Expanded
My friends, there are a few inescapable truths:- Pharma does not...
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PYC (ASX) to my watchlist
(20min delay)
|
|||||
Last
13.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $629.9M |
Open | High | Low | Value | Volume |
13.5¢ | 13.5¢ | 12.5¢ | $919.8K | 7.025M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 12715 | 13.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
13.5¢ | 276517 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 8400 | 0.130 |
3 | 516000 | 0.125 |
7 | 97726 | 0.120 |
6 | 971565 | 0.115 |
4 | 231634 | 0.110 |
Price($) | Vol. | No. |
---|---|---|
0.135 | 276517 | 3 |
0.140 | 1863642 | 7 |
0.145 | 750000 | 2 |
0.150 | 762617 | 6 |
0.165 | 28000 | 2 |
Last trade - 16.10pm 21/06/2024 (20 minute delay) ? |
Featured News
PYC (ASX) Chart |
The Watchlist
FHE
FRONTIER ENERGY LIMITED
Adam Kiley, CEO
Adam Kiley
CEO
SPONSORED BY The Market Online